Trial Profile
A multiple dose study of HP-3060 in patients with allergic rhinitis.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Emedastine (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 17 Dec 2015 New trial record